While Chemours Company has overperformed by 1.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CC fell by -20.17%, with highs and lows ranging from $39.05 to $15.10, whereas the simple moving average fell by -14.41% in the last 200 days.
On March 05, 2024, UBS Downgraded Chemours Company (NYSE: CC) to Neutral. A report published by BMO Capital Markets on February 29, 2024, Downgraded its rating to ‘Underperform’ for CC. RBC Capital Mkts also Upgraded CC shares as ‘Outperform’, setting a target price of $40 on the company’s shares in a report dated December 01, 2023. BofA Securities June 22, 2023d the rating to Neutral on June 22, 2023, and set its price target from $41 to $37. UBS January 24, 2023d its ‘Neutral’ rating to ‘Buy’ for CC, as published in its report on January 24, 2023. BofA Securities’s report from January 11, 2023 suggests a price prediction of $40 for CC shares, giving the stock a ‘Buy’ rating. RBC Capital Mkts also rated the stock as ‘Sector Perform’.
Analysis of Chemours Company (CC)
With CC’s current dividend of $1.00 per share, investors can expect to earn a return regardless of performance. Further, the quarter-over-quarter decrease in sales is -16.32%, showing a negative trend in the upcoming months.
Chemours Company’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -30.21% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.08, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and CC has an average volume of 1.87M. On a monthly basis, the volatility of the stock is set at 5.80%, whereas on a weekly basis, it is put at 5.30%, with a gain of 29.37% over the past seven days. Furthermore, long-term investors anticipate a median target price of $28.43, showing growth from the present price of $26.12, which can serve as yet another indication of whether CC is worth investing in or should be passed over.
How Do You Analyze Chemours Company Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.18%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 76.70% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CC shares are owned by institutional investors to the tune of 76.70% at present.
